{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:29:28Z","timestamp":1769833768109,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,30]]},"DOI":"10.7759\/cureus.74837","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T15:47:45Z","timestamp":1732981665000},"source":"Crossref","is-referenced-by-count":2,"title":["Monitoring Response Using Circulating Tumor DNA in Undifferentiated Pleomorphic Sarcoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Amanda B","family":"Siy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carolina A","family":"Boncompagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Charville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Poultsides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen N","family":"Ganjoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/17-116","article-title":"Undifferentiated pleomorphic sarcoma after pirfenidone use: a case report","volume":"22","author":"Moore CA","year":"2018","unstructured":"Moore CA, Kapila A. Undifferentiated pleomorphic sarcoma after pirfenidone use: a case report. Perm J. 2018, 22:17-116. 10.7812\/TPP\/17-116","journal-title":"Perm J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-023-01054-7","article-title":"A league of its own? Established and emerging therapies in undifferentiated pleomorphic sarcoma","volume":"24","author":"Graves L","year":"2023","unstructured":"Graves L, Jeck WR, Grilley-Olson JE. A league of its own? Established and emerging therapies in undifferentiated pleomorphic sarcoma. Curr Treat Options Oncol. 2023, 24:212-28. 10.1007\/s11864-023-01054-7","journal-title":"Curr Treat Options Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02189-x","article-title":"Undifferentiated high-grade pleomorphic sarcoma of the colon: a rare case report and literature review","volume":"22","author":"Han X","year":"2022","unstructured":"Han X, Zhao L, Mu Y, et al.. Undifferentiated high-grade pleomorphic sarcoma of the colon: a rare case report and literature review. BMC Gastroenterol. 2022, 22:115. 10.1186\/s12876-022-02189-x","journal-title":"BMC Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5152\/TurkThoracJ.2017.16039","article-title":"Primary pulmonary malignant fibrous histiocytoma","volume":"18","author":"Co\u015fgun T","year":"2017","unstructured":"Co\u015fgun T, Tezel Y, Aky\u0131l M, Kolba\u015f \u0130, \u015een A, Tezel \u00c7. Primary pulmonary malignant fibrous histiocytoma. Turk Thorac. 2017, 18:54-6. 10.5152\/TurkThoracJ.2017.16039","journal-title":"Turk Thorac"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2021.09.032","article-title":"Comparison of features and outcomes of undifferentiated pleomorphic sarcoma of bone and soft tissue","volume":"270","author":"Gusho CA","year":"2022","unstructured":"Gusho CA, Lee L, Guntin J, Blank AT. Comparison of features and outcomes of undifferentiated pleomorphic sarcoma of bone and soft tissue. J Surg Res. 2022, 270:313-20. 10.1016\/j.jss.2021.09.032","journal-title":"J Surg Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-8-999","article-title":"Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future","volume":"12","author":"Maki RG","year":"2007","unstructured":"Maki RG. Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future. Oncologist. 2007, 12:999-1006. 10.1634\/theoncologist.12-8-999","journal-title":"Oncologist"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00660-y","article-title":"Circulating tumour DNA: looking beyond the blood","volume":"19","author":"Tivey A","year":"2022","unstructured":"Tivey A, Church M, Rothwell D, Dive C, Cook N. Circulating tumour DNA: looking beyond the blood. Nat Rev Clin Oncol. 2022, 19:600-12. 10.1038\/s41571-022-00660-y","journal-title":"Nat Rev Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer","volume":"30","author":"Nakamura Y","year":"2024","unstructured":"Nakamura Y, Watanabe J, Akazawa N, et al.. ctDNA-based molecular residual disease and survival in resectable colorectal cancer. Nat Med. 2024, 30:3272-83. 10.1038\/s41591-024-03254-6","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0029","article-title":"Circulating tumor DNA in lymphoma: principles and future directions","volume":"3","author":"Roschewski M","year":"2022","unstructured":"Roschewski M, Rossi D, Kurtz DM, Alizadeh AA, Wilson WH. Circulating tumor DNA in lymphoma: principles and future directions. Blood Cancer Discov. 2022, 3:5-15. 10.1158\/2643-3230.BCD-21-0029","journal-title":"Blood Cancer Discov"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.04.006","article-title":"Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib","volume":"34","author":"Serrano C","year":"2023","unstructured":"Serrano C, Bauer S, G\u00f3mez-Peregrina D, et al.. Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib. Ann Oncol. 2023, 34:615-25. 10.1016\/j.annonc.2023.04.006","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00253","article-title":"Utility of circulating tumor DNA in the management of patients with GI stromal tumor: analysis of 243 patients","volume":"4","author":"Arshad J","year":"2020","unstructured":"Arshad J, Roberts A, Ahmed J, Cotta J, Pico BA, Kwon D, Trent JC. Utility of circulating tumor DNA in the management of patients with GI stromal tumor: analysis of 243 patients. JCO Precis Oncol. 2020, 4:66-73. 10.1200\/PO.19.00253","journal-title":"JCO Precis Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_280749","article-title":"Chasing ctDNA in patients with sarcoma","volume":"40","author":"Coombs CC","year":"2020","unstructured":"Coombs CC, Dickherber T, Crompton BD. Chasing ctDNA in patients with sarcoma. Am Soc Clin Oncol Educ Book. 2020, 40:e351-60. 10.1200\/EDBK_280749","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6597-x","article-title":"Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors","volume":"20","author":"Serrano C","year":"2020","unstructured":"Serrano C, Vivancos A, L\u00f3pez-Pousa A, et al.. Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors. BMC Cancer. 2020, 20:99. 10.1186\/s12885-020-6597-x","journal-title":"BMC Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.926405","article-title":"Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents","volume":"10","author":"Seidel MG","year":"2022","unstructured":"Seidel MG, Kashofer K, Moser T, et al.. Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents. Front Pediatr. 2022, 10:926405. 10.3389\/fped.2022.926405","journal-title":"Front Pediatr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0987","article-title":"A comprehensive circulating tumor DNA assay for detection of translocation and copy-number changes in pediatric sarcomas","volume":"20","author":"Shah AT","year":"2021","unstructured":"Shah AT, Azad TD, Breese MR, et al.. A comprehensive circulating tumor DNA assay for detection of translocation and copy-number changes in pediatric sarcomas. Mol Cancer Ther. 2021, 20:2016-25. 10.1158\/1535-7163.MCT-20-0987","journal-title":"Mol Cancer Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092078","article-title":"Genotyping of circulating free DNA enables monitoring of tumor dynamics in synovial sarcomas","volume":"14","author":"Eisenhardt AE","year":"2022","unstructured":"Eisenhardt AE, Brugger Z, Lausch U, et al.. Genotyping of circulating free DNA enables monitoring of tumor dynamics in synovial sarcomas. Cancers. 2022, 14:2078. 10.3390\/cancers14092078","journal-title":"Cancers"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-0250","article-title":"Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis","volume":"29","author":"Bui NQ","year":"2023","unstructured":"Bui NQ, Nemat-Gorgani N, Subramanian A, et al.. Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis. Clin Cancer Res. 2023, 29:2612-20. 10.1158\/1078-0432.CCR-23-0250","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0528","article-title":"Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer","volume":"5","author":"Reinert T","year":"2019","unstructured":"Reinert T, Henriksen TV, Christensen E, et al.. Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer. JAMA Oncol. 2019, 5:1124-31. 10.1001\/jamaoncol.2019.0528","journal-title":"JAMA Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010157","article-title":"Feasibility of longitudinal ctDNA assessment in patients with uterine and extra-uterine leiomyosarcoma","volume":"15","author":"Zhou M","year":"2022","unstructured":"Zhou M, Bui N, Rathore R, et al.. Feasibility of longitudinal ctDNA assessment in patients with uterine and extra-uterine leiomyosarcoma. Cancers (Basel). 2022, 15:157. 10.3390\/cancers15010157","journal-title":"Cancers (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15902-9","article-title":"Circulating tumor DNA in the monitoring of soft tissue sarcoma treatment and recurrence","volume":"31","author":"Sun BJ","year":"2024","unstructured":"Sun BJ, Li AY, Hur DG, Zhou M, Poultsides GA, Delitto DJ, Lee B. Circulating tumor DNA in the monitoring of soft tissue sarcoma treatment and recurrence. Ann Surg Oncol. 2024, 31:7682-4. 10.1245\/s10434-024-15902-9","journal-title":"Ann Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/213109-monitoring-response-using-circulating-tumor-dna-in-undifferentiated-pleomorphic-sarcoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T15:47:47Z","timestamp":1732981667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/213109-monitoring-response-using-circulating-tumor-dna-in-undifferentiated-pleomorphic-sarcoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.74837","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,30]]}}}